Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05743283

Efficacy of SynEx Wound Rinse in Civilian Surrogates of Combat Injury Wounds

The purpose of this interventional study is to compare SynEx Wound Cleanser with the current routine care (Saline) in traumatic wounds. Participants with gunshot, penetrating or burn wounds who participate will be asked to attend up to four study visits, use the assigned wound cleanser and complete brief surveys about their healing and well-being related to the wound healing.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

MedStar Washington Hospital Center, Washington D.C., District of Columbia, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Acute penetrating, puncture and burn wounds of the upper or lower extremity that meet the inclusion and exclusion criteria for the wound type:
  • Penetrating, puncture or laceration wounds: stage II-III (partial to full thickness loss of dermis) excluding diabetic or venous wounds, and pressure ulcers and perforated wounds (except gunshot wounds) and wounds with exposed bones, facia or muscle.
  • Gunshot wounds (GSW): Grade I - II on the Red Cross Classification of War Wounds6 (diameter of entry + exit wounds < 10 cm, wound cavity or not, no fracture or fraction without clinically significant comminution). Non-penetrating, penetrating, or perforated GSW are included. GSW with suspected vascular injuries or nerve damage are excluded.
  • Burns: partial thickness injury ≤ 9% TBSA. Thermal burn from flame or scald, chemical burns, and electrical burn are included. Radiation and frostbite burns are excluded.
  • Males and females ≥18 years old.
  • Has access to a computer or mobile device for telepresence visits.
  • Able to give informed consent and willing to comply with all required study procedures.

Exclusion criteria

  • Any wound likely to require irrigation and debridement in an operating room (OR) setting.
  • Concomitant processes sustained contemporaneously with the dermal injury (e.g., inhalational injury requiring ventilation, electrical injury with cardiac damage or arrhythmia, sepsis, traumatic brain injury, other serious or unstabilized organ damage from trauma, etc.).
  • > 72 hrs from initial injury.
  • Pregnant or lactating females.
  • Patients with known allergy(ies) to any of the components of the study irrigation system.
  • Patients who are considered by the investigator for any reason to be an unsuitable candidate.

Treatment and study plan

SynEx Wound Cleanser

Device

SynEx is a concentrated form of SynePure®, an FDA 510(k) cleared aqueous, osmotically balanced wound cleanser containing patented chitosan derivatives. The ingredients are USP purified water, chitosan arginine (a patented chitosan derivative), sorbitol powder, and betaine. SynEx cleanser is packaged in a collapsible plastic pouch for reconstitution in water before debriding and cleansing a wound.

Saline

Other

The saline solution is composed of water and salt. It is packaged in a collapsible plastic pouch.

Primary outcomes

  1. Wound healing environment composite score

    Time frame: 14 days

    The composite score is a summation of wound characteristics such size, depth, edges and undermining. Scores range from range of 13 to 60, representing wound regeneration to degeneration respectively).

Study contacts

Contact information is provided by the study sponsor or research team.

Kaveri Parker, PhD

CONTACT

[email protected]

(909) 447-6858

Shenda Baker, PhD

CONTACT

[email protected]

(909) 447-6858

Sponsors and collaborators

Lead sponsor

Synedgen, Inc.

Industry

Collaborators

  • Medical Technology Enterprise Consortium
  • United States Department of Defense

Registry information

Official study title

Efficacy of SynEx™ Wound Rinse in Civilian Surrogates of Combat Injury Wounds

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Feb 24, 2023
Registry last updated
May 16, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.